Cargando…
Follow-up in non-muscle invasive bladder cancer: facts and future
Patients with non-muscle invasive bladder cancer (NMIBC) have high recurrence and progression rates in spite of tumor resection and adjuvant instillation therapy. To detect recurrences and progression, these patients remain under frequent follow-up. Follow-up, however, is not well defined. Frequency...
Autor principal: | Witjes, J. Alfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571151/ https://www.ncbi.nlm.nih.gov/pubmed/33367941 http://dx.doi.org/10.1007/s00345-020-03569-2 |
Ejemplares similares
-
Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer
por: Hendricksen, Kees, et al.
Publicado: (2009) -
Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009) -
Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo(®) working party
por: Alfred Witjes, J., et al.
Publicado: (2009) -
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model
por: Falke, Johannes, et al.
Publicado: (2018) -
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)